Strategies of Coping with Stress and the Quality of Life in Relation to the Adherence to Therapeutic Recommendations in MS — Affected Patients
DOI:
https://doi.org/10.15225/PNN.2021.10.3.4Keywords
adherence, coping with stress, multiple sclerosisAbstract
Introduction. Multiple sclerosis (MS) is a chronic, autoimmune disease of the central nervous system, which affects young adults between 20–40 years old. The incidence of MS is increasing worldwide. The symptoms vary and depend on which part of the nervous system is affected. Stress is very common in patients with MS. It can be a risk factor related with relapses of the disease. Coping is defined as the behavioural and cognitive efforts used in an attempt to deal with stressful events. In a long-term treatment, disease modifying therapies are used to reduce the risk of the progression and severity of MS, and reduce the risk of disability. The adherence to therapy has a crucial role in the effectiveness of drugs.
Aim. The aim of the study was to assess the correlation between coping strategies and quality of life in multiple sclerosis patients depending on the degree of adherence.
Material and Methods. The study was conducted in 226 patients suffering from MS.
Results. It was demonstrated that 23.5% of respondents do not follow recommended treatments. Both adherent and non-adherent patients gave the highest grade to their quality of life in its social and psychological aspects. The most often used strategies of coping with stress both in adherent and non-adherent patients were as follows: active coping, planning, positive reframing, acceptance, seeking emotional support and seeking instrumental support. On the other hand, substance use was the least frequently used strategy, irrespective of the adherence level.
Conclusions. The use of the coping-with-stress strategy, associated with an active problem solving and seeking support, plays a positive role in the quality of life of MS patients adhering to therapeutic recommendations. The use of avoidance strategies, i.e. the not taking of actions as well as self-blaming, reduces the quality of life in MS patients, both adherers and non-adherers to recommendations. (JNNN 2021;10(3):112–119)
References
Walton C., King R., Rechtman L. et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816–1821.
Filippi M., Bar-Or A., Piehl F. et al. Multiple sclerosis. Nat Rev Dis Primers. 2018;4(1):43.
Mohr D.C., Hart S.L., Julian L., Cox D., Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ. 2004;328(7442):731.
Benito-León J. Stress and multiple sclerosis: what’s new? Neuroepidemiology. 2011;36(2):121–122.
Buljevac D., Hop W.C., Reedeker W. et al. Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. BMJ. 2003;327(7416):646.
Mitsonis C.I., Zervas I.M., Mitropoulos P.A. et al. The impact of stressful life events on risk of relapse in women with multiple sclerosis: a prospective study. Eur Psychiatry. 2008;23(7):497–504.
Sternberg E.M. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol. 2001;169(3):429–435.
Can Y.S., Iles-Smith H., Chalabianloo N. et al. How to Relax in Stressful Situations: A Smart Stress Reduction System. Healthcare (Basel). 2020;8(2):100.
Carver C.S., Scheier M.F., Weintraub J.K. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989;56(2):267–283.
Kotas R., Nowakowska-Kotas M., Budrewicz S., Pokryszko-Dragan A. The Level of Stress and Coping Strategies in Patients with Multiple Sclerosis and Their Relationships with the Disease Course. J Clin Med. 2021;10(17):3916.
Kołtuniuk A., Kazimierska-Zając M., Cisek K., Chojdak-Łukasiewicz J. The Role of Stress Perception and Coping with Stress and the Quality of Life Among Multiple Sclerosis Patients. Psychol Res Behav Manag. 2021;14:805–815.
Lublin F.D., Reingold S.C., Cohen J.A. et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278–286.
Łabuz-Roszak B., Kubicka-Bączyk K., Pierzchała K. i wsp. Jakość życia chorych na stwardnienie rozsiane — związek z cechami klinicznymi choroby, zespołem zmęczenia i objawami depresyjnymi. Psychiatr Pol. 2013;47(3):433–442.
Dargahi N., Katsara M., Tselios T. et al. Multiple Sclerosis: Immunopathology and Treatment Update. Brain Sci. 2017;7(7):78.
Evans C., Marrie R.A., Yao S. et al. Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study. BMJ Open. 2021;11(2):e043930.
Wicks P., Massagli M., Kulkarni A., Dastani H. Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ). J Med Internet Res. 2011;13(1):e12.
Carver C. (adaptacja Juczyński Z., Ogińska-Bulik N.). Mini-COPE — Inwentarz do pomiaru radzenia sobie ze stresem. W: Narzędzia pomiaru stresu i radzenia sobie ze stresem. Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego, Warszawa 2009;45–58.
Skevington S.M., Lotfy M., O’Connell K.A., WHOQOL Group. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13(2):299–310.
Wołowicka L., Jaracz K. Polska wersja WHOQOL 100 i WHOQOL Bref. W: Wołowicka L. (Red.), Jakość życia w naukach medycznych. Wydawnictwo Uczelniane Akademii Medycznej, Poznań 2001;231–238.
Olkiewicz J., Bonek R., Filipska K., Ślusarz R. Adherence to Therapeutic Recommendations in Patients Suffering from Multiple Sclerosis. J Neurol Neurosurg Nurs. 2020;9(3):103–107.
Washington F., Langdon D. Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review. J Neurol. 2021. doi: 10.1007/s00415-021-10850-w. Online ahead of print.
Corallo F., Bonanno L., Di Cara M. et al. Therapeutic adherence and coping strategies in patients with multiple sclerosis: An observational study. Medicine (Baltimore). 2019;98(29):e16532.
Beutler L.E., Moos R.H., Lane G. Coping, treatment planning, and treatment outcome: discussion. J Clin Psychol. 2003;59(10):1151–1167.
Holland D.P., Schlüter D.K., Young C.A. et al. Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics. Mult Scler Relat Disord. 2019;27:214–222.
Carnero Contentti E., López P.A., Alonso R. et al. Coping strategies used by patients with relapsing multiple sclerosis from Argentina: correlation with quality of life and clinical features. Neurol Res. 2021;43(2):126–132.
Santangelo G., Corte M.D., Sparaco M. et al. Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity. Acta Neurol Belg. 2021;121(2):465–471.
Vanotti S., Cabral N., Eizaguirre M.B. et al. Coping strategies: Seeking personalized care in relapsing-remitting multiple sclerosis. A patient reported measure-coping responses inventory. Mult Scler J Exp Transl Clin. 2021;7(1):2055217320987588.
Wilski M., Gabryelski J., Brola W., Tasiemski T. Health-related quality of life in multiple sclerosis: Links to acceptance, coping strategies and disease severity. Disabil Health J. 2019;12(4):608–614.
Strober L.B. Quality of life and psychological well-being in the early stages of multiple sclerosis (MS): Importance of adopting a biopsychosocial model. Disabil Health J. 2018;11(4):555–561.
Grech L.B., Kiropoulos L.A., Kirby K.M., Butler E., Paine M., Hester R. Target Coping Strategies for Interventions Aimed at Maximizing Psychosocial Adjustment in People with Multiple Sclerosis. Int J MS Care. 2018;20(3):109–119.
Garay-Sevilla M.E., Porras J.S., Malacara J.M. Coping strategies and adherence to treatment in patients with type 2 diabetes mellitus. Rev Invest Clin. 2011;63(2):155–161.
Farran N., Ammar D., Darwish H. Quality of life and coping strategies in Lebanese Multiple Sclerosis patients: A pilot study. Mult Scler Relat Disord. 2016;6:21–27.
Aldebot S., de Mamani A.G. Denial and acceptance coping styles and medication adherence in schizophrenia. J Nerv Ment Dis. 2009;197(8):580–584.
Aksoy A., Kelleci M. Relationship Between Drug Compliance, Coping with Stress, and Social Support in Patients with Bipolar Disorder. Dusunen Adam J Psychiatry Neurol Sci. 2016;29(3):210–218.
Brito D.C., Marsicano E.O., Grincenkov F.R., Colugnati F.A., Lucchetti G., Sanders-Pinheiro H. Stress, coping and adherence to immunosuppressive medications in kidney transplantation: a comparative study. Sao Paulo Med J. 2016;134(4):292–299.
Wilski M., Brola W., Łuniewska M., Tomczak M. The perceived impact of multiple sclerosis and self-management: The mediating role of coping strategies. PLoS One. 2021;16(3):e0248135.
Downloads
Published
How to Cite
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 290
Number of citations: 0